Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
5 Stock Gainers for Monday: Nikola, Silvercorp Metals, Trevena
By Rob Lenihan
Aug 10, 2020 4:18 PM EDT
PRESS RELEASES
Trevena, Inc. Provides Update On Commercial Launch Activities For OLINVYK™ And Announces Anticipated Pipeline Catalysts
By GlobeNewswire
Jan 6, 2021 7:00 AM EST
PRESS RELEASES
Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator At The American College Of Neuropsychopharmacology 59th Annual Meeting
By GlobeNewswire
Dec 10, 2020 8:43 AM EST
PRESS RELEASES
Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile Of OLINVYK™ (oliceridine) Injection In Pain And Therapy
By GlobeNewswire
Nov 20, 2020 7:00 AM EST
PRESS RELEASES
Trevena Announces Receipt Of Milestone Payment Under Partnership In China With Jiangsu Nhwa Pharmaceutical Co.
By GlobeNewswire
Aug 20, 2020 7:36 AM EDT
PRESS RELEASES
Trevena Announces Pricing Of $50 Million Public Offering Of Common Stock
By GlobeNewswire
Aug 12, 2020 9:27 AM EDT
PRESS RELEASES
Trevena Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Aug 11, 2020 4:01 PM EDT
INVESTING
5 Stock Gainers for Monday: Nikola, Silvercorp Metals, Trevena
By Rob Lenihan
Aug 10, 2020 4:18 PM EDT
PRESS RELEASES
Trevena Announces Advancement Of Oliceridine Clinical Development In China By Jiangsu Nhwa Pharmaceutical Co.
By GlobeNewswire
Jun 3, 2020 8:02 AM EDT
PRESS RELEASES
Trevena Announces Publication Of Comprehensive Review Of Oliceridine Data
By GlobeNewswire
Apr 23, 2020 7:00 AM EDT
PRESS RELEASES
Trevena Announces FDA Has Set PDUFA Date Of August 7, 2020 For Oliceridine
By GlobeNewswire
Mar 5, 2020 7:01 AM EST
PRESS RELEASES
Trevena Appoints Scott Applebaum As Chief Legal And Compliance Officer And SVP Of Regulatory Affairs
By GlobeNewswire
Feb 13, 2020 7:00 AM EST
PRESS RELEASES
Trevena To Present At The 2020 BIO CEO & Investor Conference
By GlobeNewswire
Feb 5, 2020 7:00 AM EST
STOCKS
This $3 Biotech Stock Is Making an 11% Move Thursday
By Armie Margaret Lee
Jul 13, 2017 9:28 AM EDT
HEALTH
Biotech Movers: Aratana Offering Priced Below Market, Shares Fall
By Armie Margaret Lee
May 4, 2017 9:25 AM EDT
STOCKS
Endo international, AngioDynamics Lead Biotech Movers
By Alicia McElhaney
Apr 7, 2017 9:25 AM EDT
STOCKS
Trevena, Synergy Lead Biotech Movers
By Alicia McElhaney
Apr 6, 2017 10:32 AM EDT
STOCKS
Regenxbio Leads Biotech Movers Ahead of Market's Open
By Alicia McElhaney
Mar 22, 2017 9:31 AM EDT
STOCKS
Biotech movers: Argos plummets 72%
By Alicia McElhaney
Feb 22, 2017 8:52 AM EST
STOCKS
Sarepta's priority review voucher leads biotech movers
By Alicia McElhaney
Feb 21, 2017 10:09 AM EST
STOCKS
Trevena makes case for better post-surgical opioid with new study data
By Adam Feuerstein
Feb 21, 2017 9:07 AM EST
VIDEO
What You Should Know About Trevena's New Painkiller
By TheStreet Staff
Feb 21, 2017 9:06 AM EST
INVESTING
No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass
By Doug Kass
Nov 18, 2016 9:00 PM EST
STOCKS
Trevena pain drug anointed 'Breakthrough Therapy' by FDA
By Adam Feuerstein
Feb 22, 2016 8:33 AM EST
OPINION
5 Stocks Poised for Breakouts
By Roberto Pedone
Oct 23, 2015 7:52 AM EDT
